Katie Coltart > Linklaters LLP > London, England > Lawyer Profile
Linklaters LLP Offices
ONE SILK STREET
LONDON
EC2Y 8HQ
England
- Firm Profile
- Go to...
Katie Coltart
Work Department
Intellectual Property
Position
Katie is a patent litigation specialist with a wealth of experience across the life sciences, telecoms and technology sectors. Katie is well-versed in dealing with major cross-border matters requiring significant coordination across multiple forums, and with a degree in chemistry and biology she is well-placed to advise on highly technical subject matters.
Katie has worked on the litigation of patents across a broad spectrum of technological subject matters, including those relating to antibody and other protein biologics, biosimilars, biological product development and screening platforms, medical devices, medical diagnostics and sequencing technologies, 2G, 3G, 4G and 5G telecommunications, connected cars, consumer products and FRAND/SEP licensing.
Career
2023 to present Linklaters LLP; 2018 to 2023 Kirkland & Ellis International LLP; 2016-2018 self-employed Legal Consultant; 2009-2015 Allen & Overy LLP
Memberships
The Law Society of England & Wales; International Association for the Protection of Intellectual Property (AIPPI); Pharmaceutical Trade Marks Group (PTMG); ChIPs Network; IPSoc
Education
University of Oxford (Postgraduate Diploma in Intellectual Property Law and Practice, 2012); College of Law, London (Bachelor of Laws; Legal Practice Course, 2008); College of Law, London (Post-Graduate Diploma in Law, 2007); Durham University (B.Sc., Biology and Chemistry, 2006).
Lawyer Rankings
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
(Next Generation Partners)London > Industry focus > Life sciences and healthcare
The team at Linklaters LLP has broad expertise spanning trade mark infringement disputes, joint R&D agreements, and supply and logistics arrangements, often assisting financial sponsors, insurers and medical device companies. The group is also noted for its expertise in data protection, regulatory investigation, and product liability matters. Aisling Zarraga co-heads the practice, and has a great deal of expertise in handling both public and private M&A issues and joint ventures for international pharmaceutical companies, healthcare service providers and biotech corporates. Co-head Marly Didizian
has broad knowledge surrounding carve outs, pharmaceutical supply chains, and advance purchase agreements involving vaccine manufacturers. Since publication, Katie Coltart has joined from Kirkland & Ellis International LLP.
Lawyer Rankings
- Next Generation Partners London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Bank lending: investment grade debt and syndicated loans
- Dispute resolution > Banking litigation: investment and retail
- Risk advisory > Corporate governance
- Finance > Corporate restructuring & insolvency
- Risk advisory > Data protection, privacy and cybersecurity
- Finance > Debt capital markets
- Finance > Derivatives and structured products
- Industry focus > Emerging markets
- Employment > Employee share schemes
- Employment > Employers
- Real estate > Environment
- Corporate and commercial > Equity capital markets – mid-large cap
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: contentious
- Corporate and commercial > Financial services: non-contentious/regulatory
- TMT (technology, media and telecoms) > Fintech
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Projects, energy and natural resources > Infrastructure: Project finance and development
- TMT (technology, media and telecoms) > IT and telecoms
- Crime, fraud and licensing > Fraud: civil
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Projects, energy and natural resources > Mining and minerals
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Projects, energy and natural resources > Power (including electricity, nuclear and renewables)
- Transport > Rail
- Investment fund formation and management > Real estate funds
- Finance > Securitisation
- Projects, energy and natural resources > Water
Firm Rankings
- Corporate and commercial > Commercial contracts
- Dispute resolution > Commercial litigation: premium
- Real estate > Commercial property: development
- Real estate > Commercial property: investment
- Dispute resolution > Competition litigation
- Corporate and commercial > Corporate tax
- Crime, fraud and licensing > Fraud: civil
- Finance > High yield
- Insurance > Insurance: corporate and regulatory
- Industry focus > Life sciences and healthcare
- Projects, energy and natural resources > Oil and gas
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Investment fund formation and management > Private funds
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Trade finance
- Public sector > Administrative and public law
- Real estate > Commercial property: corporate occupiers
- Real estate > Construction: non-contentious
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Dispute resolution > International arbitration
- Dispute resolution > Public international law
- Industry focus > Retail and consumer
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Finance > Transport finance and leasing
- TMT (technology, media and telecoms) > Sport
- Real estate > Commercial property: corporate occupiers